InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,214.08
(
0.51%
)
US TECH 100
17,714.00
(
0.41%
)
Dow Jones
39,387.76
(
0.00%
)
Brent Oil
84.15
(
0.23%
)
Bitcoin
63,233.29
(
0.29%
)
Post# of 251778
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

kris_kade

Send PM Follow Ignore
Followers 22
Posts 1671
Boards Moderated 0
Alias Born 12/12/2006

kris_kade

Re: bellweather1 post# 227229

Monday, 12/02/2019 12:37:30 PM

Monday, December 02, 2019 12:37:30 PM

Post# of 251778
Thanks for chiming in. Probably that's singular reason company thinks maximizing the rapid uptake duration of melox w/o compromising its half-life will work.

Likely same reason for initiating INTERCEPT trial too to stop migraine before even it begins.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up